Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An announcement from Precigen ( (PGEN) ) is now available.
On September 15, 2025, Precigen, Inc. saw the conversion of 79,000 shares of its 8.00% Series A Convertible Perpetual Preferred Stock into 54,937,411 shares of common stock. This conversion was executed under the terms of the company’s Amended and Restated Articles of Incorporation, with the common stock issued on September 17, 2025. The transaction was conducted under an exemption from registration, involving an exchange with existing security holders without any commission or remuneration for solicitation.
The most recent analyst rating on (PGEN) stock is a Hold with a $3.00 price target. To see the full list of analyst forecasts on Precigen stock, see the PGEN Stock Forecast page.
Spark’s Take on PGEN Stock
According to Spark, TipRanks’ AI Analyst, PGEN is a Neutral.
Precigen’s overall stock score reflects a mix of strong technical momentum and positive corporate events, offset by weak financial performance and valuation concerns. The company’s recent strategic moves and product approvals provide growth potential, but financial instability remains a significant risk.
To see Spark’s full report on PGEN stock, click here.
More about Precigen
Average Trading Volume: 8,033,408
Technical Sentiment Signal: Buy
Current Market Cap: $1.07B
See more insights into PGEN stock on TipRanks’ Stock Analysis page.